您的当前位置:首页 > 行业数据 > SGC001注射液于2024年8月获批I期临床
图片属性
图片格式:PNG 图片大小:239KB 图片尺寸:1735*843
同报告图片
 / 4
SGC001注射液于2024年8月获批I期临床_第1页
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
SGC001注射液于2024年8月获批I期临床_第2页
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
SGC001注射液于2024年8月获批I期临床_第3页
SGC001注射液于2024年8月获批I期临床_第4页
SGC001注射液于2024年8月获批I期临床_第5页
所属报告: 热景生物-公司首次覆盖报告:特色IVD与创新药双轮驱动SGC001市场潜力大-250713(32页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠